Double-blind, placebo-controlled evaluation of biorest liposomal alendronate in diabetic patients undergoing PCI: The BLADE-PCI trial.

Généreux, Philippe; Chernin, Gil; Assali, Abid R; Peruga, Jan Z; Robinson, Simon D; Schampaert, Erick; Bagur, Rodrigo; Mansour, Samer; Rodés-Cabau, Josep; McEntegart, Margaret; Gerber, Robert; L'Allier, Philippe; de Silva, Ranil; Daneault, Benoit; Aggarwal, Suneil K; Dzavík, Vladimír; Ozan, M Ozgu; Ben-Yehuda, Ori; Maehara, Akiko; Stone, Gregg W; Jonas, Michael

Généreux, Philippe; Chernin, Gil; Assali, Abid R; Peruga, Jan Z; Robinson, Simon D; Schampaert, Erick; Bagur, Rodrigo; Mansour, Samer; Rodés-Cabau, Josep; McEntegart, Margaret; Gerber, Robert; L'Allier, Philippe; de Silva, Ranil; Daneault, Benoit; Aggarwal, Suneil K; Dzavík, Vladimír; Ozan, M Ozgu; Ben-Yehuda, Ori; Maehara, Akiko; Stone, Gregg W; Jonas, Michael.

Affiliation

Généreux P; Morristown Medical Center, Gagnon Cardiovascular Institute, Morristown, NJ. Electronic address: philippe.genereux@atlantichealth.org.
Chernin G; Kaplan Medical Center, Nephrology Institute, Hebrew University School of Medicine, Rehovot, Israel.
Assali AR; Department of Cardiology, Rabin Medical Center, Petach Tikva, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Peruga JZ; Department of Cardiology, Medical University of Lodz, Lodz, Poland.
Robinson SD; Royal Jubilee Hospital, Victoria Heart Institute Foundation, Victoria, British Columbia, Canada.
Schampaert E; Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada.
Bagur R; Division of Cardiology, Department of Medicine, London Health Sciences Centre, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Mansour S; Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada.
Rodés-Cabau J; Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, Québec, Canada.
McEntegart M; Golden Jubilee National Hospital, Glasgow, United Kingdom.
Gerber R; Conquest Hospital, London, United Kingdom.
L'Allier P; Montreal Heart Institute, Montreal, Québec, Canada.
de Silva R; National Heart and Lung Institute, Imperial College London and Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom.
Daneault B; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Québec, Canada.
Aggarwal SK; Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.
Dzavík V; Peter Munk Cardiac Centre, Toronto General Hospital Research Institute, Toronto, Ontario, Canada.
Ozan MO; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY.
Ben-Yehuda O; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; Division of Cardiology, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY; University of California - San Diego, San Diego, CA.
Maehara A; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; Division of Cardiology, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, NY.
Stone GW; Clinical Trials Center, Cardiovascular Research Foundation, New York, NY; The Zena and Michael A. Wiener Cardiovascular Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
Jonas M; Heart Institute, Kaplan Medical Center, Hebrew University School of Medicine, Rehovot, Israel.

Am Heart J ; 249: 45-56, 2022 07.

Article de En | MEDLINE | ID: mdl-35305955

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie des artères coronaires / Diabète / Endoprothèses à élution de substances / Intervention coronarienne percutanée Type d'étude: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies Limites: Humans Langue: En Journal: Am Heart J Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google